How inflammatory responses are mechanistically modulated by nicotinic acetylcholine receptors (nAChR), especially by receptors composed of alpha7 (a7) subunits, is poorly defined. This includes a precise definition of cells that express a7 and how these impact on innate inflammatory responses. To this aim we used mice generated through homologous recombination that express an Ires-Cre-recombinase bi-cistronic extension of the endogenous a7 gene that when crossed with a reporter mouse expressing Rosa26-LoxP (yellow fluorescent protein (YFP) lin+ identifies a novel subpopulation of bone marrow cells that include hematopoietic progenitor cells that can re-populate an animal's inflammatory/immune system. These findings suggest that a7 exhibits a pleiotropic role in the hematopoietic system that includes both the direct modulation of proinflammatory cell composition and later in the adult the role of modulating pro-inflammatory responses that would impact upon an individual's lifelong response to inflammation and infection.
). In the adult, on average 20-25 percent of the total CD45
+ myeloid and lymphoid cells of the bone marrow (BM), blood, spleen, lymph nodes, and Peyers patches are a7 lin+ , although variability between litter mates in this value is observed. This hematopoietic a7 lin+ subpopulation is also found in Sca1 + cKit + BM cells suggesting the a7 lineage is established early during hematopoiesis and the ratio remains stable in the individual thereafter as measured for at least 18 months. Both a7 lin+ and a7 lin-BM cells can reconstitute the immune system of naïve irradiated recipient mice and the a7 lin+ :a7 lin-beginning ratio is stable in the recipient after reconstitution. Functionally the a7 lin+ :a7 lin-lineages differ in response to LPS challenge. Most notable is the response to LPS as demonstrated by an enhanced production of IL-12/ 23(p40) by the a7 lin+ cells. These studies demonstrate that a7 lin+ identifies a novel subpopulation of bone marrow cells that include hematopoietic progenitor cells that can re-populate an animal's inflammatory/immune system. These findings suggest that a7 exhibits a pleiotropic role in the hematopoietic system that includes both the direct modulation of proinflammatory cell composition and later in the adult the role of modulating pro-inflammatory responses that would impact upon an individual's lifelong response to inflammation and infection.
Introduction
Modulation of inflammatory responses by nicotinic acetylcholine receptors (nAChR), ligand gated ion channels permeable to calcium and sodium that are either composed of various combinations of different alpha and beta subunits, is mainly associated to the homomeric alpha7 subtype (a7; [1] ). In addition to its role in modulating central neurotransmission, a7 is also expressed by non-neuronal [2] cells including astrocytes, keratinocytes, epithelial cells, adipocytes and those of the immune system including macrophages and lymphocytes [2] [3] [4] [5] [6] [7] [8] . A function of a7 expression by immune cells is in part to modulate inflammatory responses through affecting the production of inflammatory cytokines as well as chemokines [5, [9] [10] [11] [12] [13] [14] . For example, upon exposure of skin to ultraviolet radiation a7 KO mice exhibit enhanced expression of pro-inflammatory chemokines and cytokines relative to control wild-type mice, and there is a greater influx of inflammatory cells to the exposed tissue of the a7 KO mice [12, 14] . Collectively these and similar studies as cited above have shown the null mutation of a7 leads to greater inflammation suggesting that the expression of this receptor is associated with down-regulation of inflammatory responses. However, depending on the tissue and cell type that expresses a7, there can be diverse outcomes. For example, nicotine (a ligand to a7) exacerbates Crohn's disease while it can ameliorate a certain degree of inflammation in ulcerative colitis [15] , also a disease of the intestine. To better understand the mechanisms involved in a7 modulation of inflammation a greater understanding of cells expressing this receptor is required. Identifying cells that express a7 has been difficult due in part to the relatively low abundance of receptor expression and the poor reliability of commercial reagents used for their detection [16, 17] . Thus, there has been a challenge to clearly identify the cells that express a7 and then determine their relative response when exposed to ligand (e.g., nicotine). Toward resolving this limitation we employed homologous recombination to introduce an IRES-Cre bi-cistronic gene cassette after the 39 end of the mouse a7 gene (Chrna7) [18] [19] [20] . Upon crossing these mice with females harboring the conditional reporter; Rosa26-loxP (yellow fluorescent protein, YFP) [21] [22] [23] , offspring are referred to as a7
Cre:YFP [18] . In these mice a7 lineage positive cells (a7 lin+ ) are identified by YFP expression using flow cytometric analysis. This has enabled us examine with heretofore unavailable precision and accuracy the participation by a7 lin+ cells in a pro-inflammatory environment. In this report we describe the expression of a7 lin+ cells of the hematopoietic system using the a7
Cre 
Materials and Methods

Reagents
EDTA (Sigma Aldrich, St. Louis, MO), bovine serum albumin, Fraction V (BSA, Roche, Indianapolis, IN), sodium azide (SA, Thermo Fisher Scientific Inc., Waltham, MA), brefeldin A (eBioscience, San Diego, CA), IC Fixation & Permeabilization kit (eBioscience). Antibodies: Ly6G (clone IA8, BD Bioscience Pharmingen, San Jose, CA), CD45R/B220 (clone RA3-6B2, BD Bioscience Pharmingen), CD4 (clone GHK1.5, BD Bioscience Pharmingen), CD8a (clone 53-6.7, BD Bioscience Pharmingen), Ly6C (clone AL-21, BD Bioscience Pharmingen), CD11b (clone M1/70, BD Bioscience Pharmingen), Gr1(RB6-8C5, BD Bioscience Pharmingen), Fc block (BD Bioscience Pharmingen), F480 (clone BM8, eBioscience, San Diego, CA). TNFa (clone MP6-XT22, eBioscience), IL-12/23(p40)(clone C17.8, eBioscience), IL-6 clone MP5-2-F3, eBioscience) and IL-10 (clone JES5-16E3, eBioscience).
Animals
Mice were kept in accordance with the Guide for the Care and Use of Laboratory Animals and the University of Utah IACUC regulations and guidelines. Studies have been reviewed and approved by the University of Utah IACUC review committee (Approved Protocols #09-07003 and #12-06001). All mice were housed in a pathogen free environment with water and standard mouse chow provided ad libitum. Each experiment used groups of 3-5 mice that were age, gender and strain matched. C57BL/6 mice (stock # 000664) were purchased from Jackson Laboratories (Bar Harbor, ME) as were the CD45.1 mice (B6.SJL-Ptprca Pepcb/BoyJ, stock #002014). The generation and characterization of the a7 Cre mice has been described previously [18] . The Rosa26-loxP(enhanced yellow fluorescent protein (YFP)) reporter mouse line were originally from the Jackson laboratory (Stock Number 006148; see [22, 23] ).
Isolation of Cells from Blood, Spleen and Bone Marrow
Lymphoid organs were removed from sacrificed mice and manually dissociated. Bone marrow cells from the femurs and tibias were crushed in a sterile mortar and pestle, red blood cells lysed (RBC lysis buffer, eBioscience), and the cells were passed through 70 mm nylon mesh filters. Viability was routinely assessed by Trypan Blue exclusion and during Flow Cytometry analysis by exclusion of 7-AAD positive cells. Spleen and lymph node cells were isolated following gentle extrusion from the connective tissue and similarly tested for viability with Trypan Blue and 7-AAD.
Bone Marrow Reconstitution
Reconstitution of lethally irradiated recipient mice (B6.SJL, CD45.1) with donor bone marrow cells (BM cells) from a7 cre:YFP mice (CD45.2) was performed as reported previously [22, 24] . Briefly, cells were isolated from the femurs and tibias of donor mice, red blood cells were lysed and the remaining cells passed through a sterile 70 mm nylon cell strainer and washed several times. BM cells were resuspended in saline containing 2% FBS at a concentration of 10 7 cells per ml. These cells were then sorted with a Becton Dickenson cells sorter (BD FACSAria III) using BD FACSDiva TM software for YFP + and YFP -cells. Isolated cells were assessed for purity, which was greater than 95%, washed with saline/FBS and resuspended to a density of 1 to 2610 6 cells per 100 ml. During this process the recipient mice (CD45.1) were exposed to a split dose (266 Gy) at a 3 hour interval using a Shepherd Mark I 137Cs source (JL Shepherd and Associates, Glendale, CA, http://www.jlshepherd.com) at a dose rate of 0.8 Gy/minute. Bone marrow cells were transplanted by the retroorbital route under tribromoethanol (Avertin) anesthesia (1:80 dilution of 1 mg/ml sterile solution, 0.5 ml/mouse, i.p.) at a dose of 1 to 2610 6 total cells in 0.1 ml volume. After cell injection, the recipient mice were placed on acidified, antibiotic water. Water is first adjusted to pH 2.6 with concentrated HCl and then autoclaved. To this 1 liter was added neomycin and then sterilized by filtration. Mice were kept on acidic, antibiotic water for 2 weeks after irradiation and then switched to acidic water without antibiotics for the remainder of time. Analysis of reconstitution was done at 2, 4, 6, 8 and 10 weeks post-transplant.
Enrichment of Bone Marrow Cells
Cells were isolated from the bone marrow of mice. Cell suspensions were pelleted by centrifugation and resuspended in 40 ml of running buffer per 10 7 cells. 10 ml of Biotin Antibody Cocktail (Mouse Lineage Cell Depletion Kit; Miltenyi Biotec) was added to the cell suspension and incubated for 10 minutes at 4-8uC followed by washing in 2 ml of running buffer and centrifuged. After the centrifugation, 30 ml of running buffer and 20 ml of Anti-Biotin Microbeads were added per 10 7 cells. Suspensions were briefly vortexed and incubated for 15 minutes at 4-8uC. Cells were washed twice by adding 2 mL running buffer per 10 7 cells and centrifuged. The cell pellets were resuspended in 4 ml of running buffer and this cell suspension was passed through a 70 mm nylon mesh filters prior to separation. Lineage committed and lineage negative cells were separated using an autoMACS cell sorter (to achieve a purity of greater than 80%.
Flow Cytometry Analysis
For flow cytometry (FC) analysis 0.5-1610 6 cells were counted, resuspended in 200 ml FACS staining buffer (PBS, 2% BSA, 0.05% EDTA, SA 0.1%) and placed into tubes on ice. For all samples, Fc receptors were blocked using 1 mg/sample Fc block for 15 minutes on ice. A cocktail of monoclonal antibodies directed against Ly6G, Ly6C, CD45R/B220, CD4, CD8a, Gr1, CD11b, or F4/80 were then added to the tubes at a concentration of 0. 
Intracellular Cytokine Analysis
At ten weeks post BMT, mice that simultaneously received a7 lin+ (1610 6 ) and/or a7 lin-(1610 6 ) cells were i.p. challenged with 25 mg of E. coli LPS (Sigma) in 100 ml Saline. Forty-eight hours later, splenocytes were isolated, resuspended in complete medium at a density 2610 6 cells/ml. Brefeldin A (3 mg/ml, eBioscience) was added to the cultures and incubated for three hours at 37uC. After incubation, cells were washed in FACS staining buffer, Fc receptors blocked with blocking antibody (eBioscience) and stained with either anti-CD11b or anti-B220 antibodies for 15 minutes at 4uC. Cells were then fixed, permeabilized (eBioscience fixation/ permeabilization kit), and additionally stained with anti-TNFa, IL-12/23(p40), IL-6, or IL-10 antibodies. Twenty thousand live nucleated cells were collected using the Accuri C6 cytometer and analyzed with FCS Express (De NOVO software, Los Angeles, CA).
Results
The Expression of a7 during Hematopoiesis Reveals Distinct a7 lin+ and a7 lin-Lineages
To assess the role of a7 in the induction of innate immune responses a precise determination of the types of cells expressing these receptors is needed. To do this we examined offspring of crosses between the a7
Cre male mice (Methods and Figure 1A and [18] and female mice harboring the ROSA26-LoxP(YFP) reporter (Methods and [21] [22] [23] ). The offspring of these crosses are referred to as a7
Cre:YFP mice. Upon bi-cistronic transcription of a7 and Cre recombinase, recombination and expression of YFP is maintained thereafter defining the a7 lineage marked cells (a7 lin+ ). Cells not expressing YFP are readily distinguished as (a7 lin-) cells using FC (Methods). Results in Figure 1B show that YFP is not detected in bone marrow of the Rosa26:LoxP(YFP) control mouse (nor in any other tissue from Rosa26:LoxP(YFP) mouse, including the spleen, not shown). As a positive control for detection of YFP in hematopoietic cells, we isolated cells from the bone marrow of Hoxb8-Ires-Cre x Rosa26:LoxP(YFP) mice [22] that is widely expressed in hematopoietic progenitors. Consistent with this expression, essentially all of the cells from the bone marrow of the Hoxb8
Cre x Rosa26:LoxP(YFP) offspring were lineage marked as identified by YFP + expression ( Figure 1C ). In contrast the detection of YFP in bone marrow cells from the a7
Cre:YFP (a7 lin+ ) mice ( Figure 1D ) is approximately 20% of bone marrow cells with the remainder being a7 lin-. Analysis of cells from several other lymphoid organs (spleen, peripheral lymph node, thymus) shows that like the bone marrow only a portion (15-22%) of the cells in this group were also a7 lin+ ( Figure 1E ). A survey using blood samples from a7
Cre:YFP mice in our colony ( Figure 1F , bar graph) shows that a7 lin+ expression ranged from the extremes of 3% to 81%. However, these mice were rare and the majority of a7 lin-cells or in bone marrow cells of the a7 KO mouse (using primers spanning exons 8-9; not shown and [12, 14] ).
Flow cytometry (FC) results ( Figure 1E ) often show two peaks of a7 
Distribution of a7 lin+ Cells in Lymphoid Organs
We next examined a7 lin+ expression in different cell populations using cell-type specific markers including Gr1 (myeloid, granulocytes), Ly6C (monocytes), Ly6G (neutrophils), CD11b (myeloid), B220 (B lymphocytes), as well as CD4 (T lymphocytes) and CD8 (cytotoxic T lymphocytes) in naïve mice. These results are shown in Figure 2 and in supplemental data ( Figure S1 ). In all lymphoid tissues and cell types examined, the percent of a7 lin+ cells averaged between 20-25% of the respective cell populations. Cell distributions in different tissues were consistent with expected populations of CD11b
+ and Gr1 + cells in the bone marrow, and lymphocytes (B and/or T) in the spleen and lymph nodes (Figure 2 and Figure  S1 ). Consistent with the results of Figure 1G , H, is that bone marrow had the highest percentage of a7 lin+hi cells while spleen and lymph nodes had proportionally more a7 lin+lo cells. This result is in accord with the results in Figure 1 showing that B220 + B cells were mainly a7
lin+lo . CD4 and CD8 positive T cells present in the spleen and lymph nodes expressed a7 lin+ cells and these cells tend to be more a7 lin+hi . We are further investigating T lymphocyte expression of a7 lin+ to determine whether the a7 lin+hi phenotype is a result of greater a7 expression.
Analysis of a7 lin+ in Bone Marrow Precursors of Myeloid and Lymphoid Cells
The observation that the ratio of a7 lin+: a7 lin-(1:5) remains stable in mice from birth to approximately 12-18 months old raised the possibility that a7 expression initially arises in a subset of precursor cells of the bone marrow which remain stable. To determine this we examined bone marrow cells based on expression of the cellular markers Sca1 and cKit. Lineage negative cells that are positive for cKit and Sca1 identify a population of hematopoietic stem cells (HSC) that give rise to both mature myeloid and lymphoid cells. Bone marrow cells were first depleted of lineage positive cells by incubation with a cocktail of lineage marker antibodies (see Methods). The lineage negative cells were then stained for Sca1 and cKit [25] . Results shown in Figure 3 show that approximately the same number of Lin 
Sca1
+ cells from the a7
Cre:YFP bone marrow were a7 lin+ ( Figure 3B ). Cre:YFP mouse [18] was constructed using homologous recombination to introduce into the 39 end of the a7 gene (Chrna7) a bi-cistronic marker cassette that includes an internal ribosome entry sequence (IRES) and Cre-recombinase (Cre). In these mice, the independent translation of a7 and Cre-recombinase is achieved when Chrna7 is expressed. B) Bone marrow cells from the Rosa26:LoxP(yellow fluorescent protein (YFP)) parental mice [21, 22] Figure S2 ). Also evident is that engrafted donor cells that are either a7 lin-or a7 lin+ cells retain their respective phenotypes indicating that CD45.2 + /a7 lin-cells do not initiate expression of a7 during maturation in the bone marrow. As shown in Figure 4 , the a7 lin+ cells that are present at week 2 are predominantly those that express the CD11b marker. With time (as shown for week 4 and 8 post-BMT) there is a shift in the relative proportion of these cells as seen by their overall decrease in percentage that is accompanied by a coordinate increase in the percentage of B220 cells (Figure 4 ). This suggests that several differences in the engrafted populations do appear between the a7 lin-and a7 lin+ mice over the 8-10 week recovery period. In particular the time course of B-cell engraftment in a7 lin+ populations is slower and less robust ( Figure 4B ,C) whereas this group exhibits greater reconstitution of CD11b + (Figure 4 ) and Gr1
+ populations ( Figure S2 ) with more prolonged expression in the blood. Supplemental data ( Figure S2 ) shows another experiment with additional cellular analysis for GR1 and CD8 as well as CD11b and B220. Each reconstitution experiment has been repeated at least 3 times with 5 to 6 recipient animals per group. 
. Lethally irradiated recipient mice (CD45.1 allele) were injected with 2610 6 of the CD45.2/a7 lin-or the CD45.2/a7 lin+ sorted cells. Mice were monitored via small blood samples for CD45.2 allele to indicate donor specific lineage of cells having cell-type specific markers (e.g., CD11b, B220). Results have been repeated at least 3 times using groups of 4 mice each and these data quantified as shown in the bottom bar graphs (mean +/2 s.e.m.). Supplemental data (Supplemental Figure 2) Figure 5A , re-analysis of the starting viable cell population after sorting and mixing (prior to injection into mice) was 40% a7 lin-and 48% a7 lin+ . Analysis of the cellular composition (a7 lin+ or a7 lin-) of the mice reconstituted with this mix is shown in Figure 5B . In keeping with more a7 lin+ cells injected, there a proportional increase in the a7 lin+ cells at weeks 2, 4, and 8 post-injection ( Figure 5B ). Two weeks post-reconstitution 59% of the cells in the blood of this recipient were a7 lin+ ( Figure 5 and Figure S2 ). However, this difference in a7 lin+ was not evident in all reconstituted mice. In at least 3 repeats of this experiment, the ratio of a7 lin-to a7 lin+ ranged between 40% to 60% a7 lin-. Data presented in Figure 5C show the combined results of these experiments in bar graphs. Regardless of a7 lin+/2 phenotype, each population of cells such as CD11b follows a similar pattern of engraftment and reconstitution suggesting that neither of these stem cell populations out-competes the other. This includes the initial robust establishment of CD11b cells and the diminished frequency of this population as well as the increase in B220 + cells. Overall, the ability to reconstitute recipient mice is equivalent at this level of examination with variations based more on mouse to mouse differences rather than the differences between a7 lin+ and a7 lin-.
To determine whether a7 lin+ bone marrow cells differentiate into more specialized immune cells in peripheral tissues, we evaluated cells from the lung alveolar space. The majority of resident cells in lung lavage fluid are alveolar macrophages (AM) that are CD11c
+ and CD11b - [26] . Upon lung lavage of a7
Cre:YFP mice we measured via FC a7 lin+ cells and found that they constitute about 20% of the CD11c + AM (not shown). Results shown in Figure 6 lin-BM cells we measured cytokine production at 10 weeks post-reconstitution. Figure 7A shows that at 8 weeks post reconstitution there were slightly more a7 lin+ cells (56%) than a7 lin-cells in the blood. Also shown in Figure 7A (right panel) is that at 10 weeks post-reconstitution there were more a7 lin+ blood cells at 48 hours post-LPS challenge. Spleen cells from these mice were assessed for intracellular cytokines by FC. Spleens from 3 individual animals were harvested 48 hours post-LPS and maintained as distinct samples (i.e., not pooled). Each animal responded in terms of cytokine production by a7 lin+ and a7 lin-cells. Figure 7B shows the isotype controls for the intracellular cytokine antibodies used to assess spleen cells for the cytokines measured (the same isotype control can be used for each cytokine measured, Methods). Results in Figure 7C show cytokine production by spleen cells isolated from the a7 Cre:YFP mouse cytokine production by a7 lin+ cells contributes substantially to the overall inflammatory response. In Figure 8A we show that cells from a naïve a7
Cre:YFP mouse have a constitutive level of TNFa expression (8.78% TNFa + :a7 lin-, and 5.63% TNFa + :a7 lin+ ) which is not unexpected since this cytokine is produced as a precursor protein and stored in the cell. Upon challenge of the mouse with LPS, TNFa is elevated in the a7 lin-and a7 lin+ spleen cells. The a7 lin+ cells contribute approximately 12% to the total TNFa response (Gate A). Therefore, while these a7 lin+ cells are functional producers of TNFa, the number of cells expressing this cytokine upon stimulation constitutes a small percentage of the response induced in the animal. Figure 7B shows intracellular staining for IL-6 which suggest that the a7 lin+ cells contribute IL-6 (30% of the total response in Gate A) to the response but not as much as the a7 lin-cells. However, upon analysis of IL-12/23(p40) it is notable that the a7 lin+ cells contribute 66% of the IL-12/23(p40) response. These studies demonstrate that; 1) A population of a7 lin+ bone marrow cells are hematopoietic progenitor cells that can repopulate an animal's inflammatory/immune system similar to a7 lin-cells; 2) The a7 lin+ and a7 lin-bone marrow precursor donor cells retain their phenotype after reconstitution of recipient animals for up to 12 weeks; 3) both a7 lin+ and a7 lin-spleen cells are functional in terms of cytokine production; and 4) a7 lin+ cells contribute more IL-12/23(p40) to an inflammatory response initiated in the a7
Cre:YFP+ mouse but also contribute other cytokines such as IL-6 and TNFa.
Discussion
The innate inflammatory response represents the first line of defense against infectious diseases. However, if an inflammatory response continues unchecked the possibility of undesirable sideeffects including chronic inflammation and tissue destruction can be anticipated. Many mechanisms exist for calming the in-flammatory response and here we report on the expression of a nicotinic receptor that is reported to have anti-inflammatory effects. There is increasing evidence that agonist (acetylcholine or nicotine) activation of the nicotinic a7 receptor expressed on inflammatory cells modulates the inflammatory response through decreasing the production of cytokines and chemokines [7, [11] [12] [13] [14] [27] [28] [29] [30] . This is in part based upon studies that compared the a7 KO mice to control WT mice. The a7 KO mouse elicits more inflammatory cytokines upon challenge and induces more cellular infiltration into the sight of inflammation. This process appears to, in some cases, be regulated through release of acetylcholine by local parasympathetic vagal efferents to impact upon a7 function and subsequently modulate the function of those cells expressing this receptor such as macrophages [4, 6] . These observations have collectively formed the cholinergic anti-inflammatory hypothesis [4, 31] . However, because similar findings are reported in tissues where parasympathetic innervation is absent, such as the skin, a7 also plays a significant role in modulating the local inflammatory environment presumably due to the local release of acetylcholine by non-neuronal cell types such as keratinocytes [7, 14, 32, 33] . Figure S2 . These experiments have been performed 3 times, 4 animals per group and the quantitation of these findings are graphically shown in (C) (mean +/2 s.e.m.). doi:10.1371/journal.pone.0057481.g005 . These populations were also mixed in even numbers (50:50) and this mixture injected into recipient mice. Recipient mice were sacrificed at 10 weeks (B) and the a7 lin phenotype measured from lung cells collected subsequent to lavage. Lung lavage cells from mice receiving a7 While both vagal and non-vagal mechanisms are consistent with the importance of a7 to impacting upon the magnitude of various pro-inflammatory responses, many questions remain regarding how the expression of a7 influences the system wide inflammatory response and how this can vary between individual animals. Our newly defined mouse models are directly applicable to resolving these issues and they offer the advantage over transgenic models of not interfering with endogenous gene expression or altering normal copy number. Further, as in this study the use of the a7 cre mouse crossed with the reporter Rosa26-loxP(YFP) reporter mouse [21] provides a reliable method to identify a7 lin+ cells through measurement of YFP expression [18, 22, 23] . While the expression of YFP is not necessarily a measure of ongoing a7 expression, a7 transcripts are present in a7 lin+ bone marrow precursor cells with the anticipated relatively low abundance of 5-10 transcripts per 100,000 b-actin transcripts.
The detection of a7 lin+ cells in mice reveals that most often between 15% and 25% of the hematopoietic cells are distinguished by this lineage marking. The ratio of a7 lin+ to a7 lin-cells is stable, as reflected by the results of measuring individual animal blood samples over a period of at least one year. In cases where aged animals (.18 months) were available, they too do not significantly deviate from the expectation of ratios defined by younger animals (not shown). Therefore, once established it appears that the representation of the a7 lin+ ratio does not substantially change throughout the animal's life. Consistent with this observation is that within the bone marrow, a subset of the Sca1 lin+ to IL-6 is also substantial (30%). These experiments were repeated 3 times with similar results. doi:10.1371/journal.pone.0057481.g008 subsequent responses resulting from IL-12/23(p40) expression. Collectively our findings support the presence of a distinct subpopulation of regenerating cells identified by a7 lin+ marking that is maintained in both immune (spleen, thymus and lymph nodes) and non-immune organs (lung), and these tend to be more pro-inflammatory than a7 lin-counterparts. A biologic significance of a7 lin+ cells may, in part, be associated with different macrophage phenotypes. Our understanding of macrophage heterogeneity is rapidly expanding and consideration of a7 lin+ as a marker of macrophage subsets is an intriguing possibility. For example, classically activated macrophages of the described M1 phenotype have a more pro-inflammatory response than those of the M2 phenotype which are associated with wound healing and repair, as well as fibrosis. Whether a7 lin+ macrophages differentiate into either M1 or M2 macrophage, or if this lineage differentiates into both but predominately into one remains to be determined. Further, if an individual animal has 20% versus 50% a7 lin+ macrophages that may be of the M1 phenotype, a more proinflammatory phenotype in the individual may be present. Similarly, diseases associated with M2 phenotype such as fibrotic diseases may be pre-disposing.
In light of the current understanding of the role a7 in proinflammatory responses, our results are somewhat perplexing. We and others have found that the a7 KO mouse has an enhanced proinflammatory response, demonstrated most often by an increase in TNFa release [13, 14, 34] . We find here that the a7 lin+ cells are those that are most responsive to stimulation with LPS and contribute substantially to the expression of certain cytokines (IL-12/23(p40)) while having little impact on the total expression of TNFa. Thus the a7 lin+ cells and the a7 KO both exhibit a more pro-inflammatory phenotype, but possibly through the apparent modulation of different cytokines. This result could reflect the complexities of a7 functional pleiotropy that are being revealed for the role this receptor has in directing a variety of developmental processes whose outcome may not be predicted by the functional role this receptor plays in the adult [18] [19] [20] . First, a7 expression exhibits onset at embryonic day 9 whereupon the pattern expands dramatically thereafter to include multiple tissues and cell types [18, 19] . Many of these sites of expression are transient and vary among specific tissues with widely diverse functions. Thus, to extend this role to this study, it would not be surprising that a7 impacts upon the inflammatory status through different mechanisms including modifying initial conditions of hematopoiesis during development and later in the adult, where a7 has a distinctly different functional role in those cells where expression is ongoing (for discussion and examples see [1, 7, [18] [19] [20] ). The presence of a stable a7 YFP+/2 ratio from birth, suggests that a likely origin of this lineage marked cell group during early embryonic hematopoiesis is the AGM (aorta-gonads-mesonephros) since a7 expression has not been detected prior to embryonic day E9.0. We are currently investigating this possibility. Second, because the antibody to p40 defines the expression of this subunit in both IL-12 and IL-23, both are being measured. Both of these cytokines have pro-inflammatory functions but IL-23 is distinct in terms of stimulating the induction of Th17 cells whereas IL-12 inhibits this induction. In the a7 KO (absence of the a7 lin+ cells), dysregulated adult cytokine modulatory regulation would lead to the observed net increase in inflammation independently of the IL-12/23(p40) mechanism. Further, a7 is uniquely modulated, both functionally and transcriptionally, by an assortment of external ligands including nicotine and dietary choline (both are a7 agonists and choline is in addition a one-carbon methyl donor; see [18] ). Both agents impact on immune and inflammatory responses in the adult [35] and they have a dramatic effect on the early developmental processes where conditional ablation of a7 lin+ cells leads to multiple birth defects including spina bifida [18] . In addition to the direct functional modulation of the receptor by a7 agonists, Chrna7 resides in a genomic region well-characterized to be regulated by methylation and parental imprinting [36, 37] . Studies to address many of these issues, such as the mechanism through which the ratio of a7 lin+ cells is set are in progress. Exposure to ligands of a7 (e.g., nicotine or dietary choline) during development may affect the number and function of the a7 lin+ cells both in vivo and in vitro. Extending the results from previous studies to the present findings suggests that receptor activation and cellular function such as cytokine production [4, 7, 38] , and genomic modifications leading to changes in gene transcription are mechanisms that are consistent with the findings from this study. One implication is that environmental-gene interactions both during pregnancy and in the adult would have varied consequences on a7 expression and function that would impact upon an individual's lifelong response to inflammation and infection.
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Figure S1 Figure 2 ). These results have been repeated at least 3 times. (TIF) Figure S2 Further identification of donor cell types in the blood of bone marrow recipient mice. Analysis of blood from recipient mice at various times post reconstitution with donor cells that were either a7 lin+ (top panels), a7 lin-(middle panels), or a 50:50 mix of the two (a7 lin+ and a7 lin-, bottom panels 
